Compounds > awd 26-06
Page last updated: 2024-11-07

awd 26-06

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID126920
MeSH IDM0168573

Synonyms (7)

Synonym
awd 26-06
98374-55-1
awd-26-06
11h-dibenzo(b,e)(1,4)diazepin-11-one, 5-((bis(2-hydroxyethyl)amino)acetyl)-8-chloro-5,10-dihydro-, monohydrochloride
2-[bis(2-hydroxyethyl)amino]-1-(8-chloro-11-hydroxy-5h-dibenzo[b,e][1,4]diazepin-5-yl)ethan-1-one--hydrogen chloride (1/1)
DTXSID70913315
11-[2-[bis(2-hydroxyethyl)amino]acetyl]-3-chloro-5h-benzo[b][1,4]benzodiazepin-6-one;hydrochloride

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The repeated dosage (25 mg every 8 h for 7 d) showed a small increase of the serum level."( [The pharmacokinetic behavior of AWD 26-06 in humans following single and multiple administration].
Feller, K; Richter, K; Terhaag, B, 1992)		0.56
"The tolerability of the compound AWD 26-06 (which is to classify as a M1-antagonist in consequence of the pharmacological investigations) was investigated in 11 healthy male persons with increasing dosage from 5 to 150 mg."( [Clinico-pharmacologic studies with a M1 receptor antagonist (substance AWD 26-06) in a phase I clinical trial].
Feller, K; Gramatté, T; Terhaag, B, 1988)		0.79
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's6 (85.71)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.89 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
pentagastrin
Pentagastrin: A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid.		3.3511organic molecular entity
ConditionIndicatedRelationship StrengthStudiesTrials